Among 90 patients with ES-SCLC, all CRS in the outpatient cohort was grade 1, and no patient in any care model was readmitted ...

At the 2026 National Summit on Hematologic Cancers, Kate Kennedy, MSN, APRN, flagged decisions where guidelines give nurses and APPs little direction.

Interim AYA-NAV data show most navigation components reached young patients with cancer as designed, though full sessions ...

Nurses and NPs share how they manage rash, stomatitis, diarrhea, dose holds, cost, and trial eligibility with oral daraxonrasib in pancreatic cancer. For Yolanda Justal, APRN, of the University of ...

As bispecifics and cell therapies move outpatient, Kate Kennedy, MSN, APRN, says nurses and APPs should focus on education ...

By 26 months, 81% of families of children with B-ALL reported job or marital changes; less frequent maintenance pulses eased expenses only.

A nurse-led educational intervention combining an in-person session and an animated video improved trial-naïve patients' ...

A 3-minute video and quick-reference list of October's 7 FDA cancer approvals, with the biomarker and monitoring points ...

Ellery Palanuk, MSN, RN, CN-BN, explains how navigators rely on multidisciplinary teams and tumor boards as breast cancer ...

Nicole Doell, MSN, RN, of Sylvester explains how nurses can address breast cancer misinformation without judgment and share ...

The approval covers IV and subcutaneous pembrolizumab and raises the TMB-H threshold from 10 to 13 mutations/megabase.